Similarly, HIF-1α promotes metabolic alterations that aid in the progression of osteosarcoma, and its elevated expression is more likely to result in poor clinicopathological traits, advanced cancer stage, metastasis, low survival, and resistance to chemotherapy [19,20,21]. This evidence concerns the gene HIF1A and osteosarcoma.